Search Within

Jamie Erin Chaft

Formats
  1. Meeting Abstract (147)
  2. Journal Article (130)
  3. Review (9)
  4. Editorial (2)
  5. Miscellaneous (2)
  6. Conference Paper (1)
  7. Guidelines (1)
  8. Research Letter (1)
Groups
  1. Department of Medicine (293)
  2. Solid Tumor Oncology Division (293)
  3. Thoracic Oncology (293)
  4. Surgery (114)
  5. Department of Pathology and Laboratory Medicine (98)
  6. GSK Faculty (76)

More Groups

People
  1. Mark Kris (107)
  2. Matthew Hellmann (68)
  3. Andreas Rimner (59)
  4. David Jones (50)
  5. Abraham Wu (47)
  6. Valerie Rusch (47)

More People

Years
  1. 2025 (9)
  2. 2024 (29)
  3. 2023 (28)
  4. 2022 (23)
  5. 2021 (23)
  6. 2020 (20)

More Years

Publications
  1. Journal of Thoracic Oncology (60)
  2. Journal of Clinical Oncology (58)
  3. International Journal of Radiation Oncology, Biology, Physics (25)
  4. Annals of Oncology (13)
  5. Journal of Thoracic and Cardiovascular Surgery (10)
  6. Clinical Cancer Research (9)

More Publications

Publishers
  1. Elsevier Inc. (102)
  2. American Society of Clinical Oncology (62)
  3. American Association for Cancer Research (23)
  4. Oxford University Press (16)
  5. Nature Publishing Group (12)
  6. Mosby Elsevier (10)

More Publishers

Results (293)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Tumor expression of TTF1 is associated with a doubling of overall survival in patients with advanced lung adenocarcinomas
    Meeting Abstract

    Hellmann, M. D.; Hilden, P. D.; Sima, C. S.; Kris, M. G.; Rekhtman, N.; Chaft, J. E.
    Journal of Thoracic Oncology (2013)

    Fulltext@MSK | Save
  • "Intention-to-treat" outcomes of sequential patients with stage IIIA lung adenocarcinomas treated with neoadjuvant chemotherapy with intent of surgical resection
    Meeting Abstract

    Hellmann, M. D.; Chaft, J. E.; Hilden, P. D.; Rusch, V. W.; Kris, M. G.
    Journal of Thoracic Oncology (2013)

    Fulltext@MSK | Save
  • High local control rates with postoperative radiation therapy in incompletely resected non-small cell lung cancer (NSCLC) patients
    Meeting Abstract

    Din, S. U.; Wu, A. J.; Gelblum, D. Y.; Foster, A.; Chaft, J. E.; Rizk, N. P.; Huang, J.; Rimner, A.
    Journal of Thoracic Oncology (2013)

    Fulltext@MSK | Save
  • Major pathologic response (<= 10% viable tumor) following neoadjuvant chemotherapy as a surrogate for overall survival in patients with pathologically documented stage IIIA (N2) lung adenocarcinomas
    Meeting Abstract

    Chaft, J. E.; Hellmann, M. D.; Rusch, V. W.; Travis, W. D.; Kris, M. G.
    Journal of Thoracic Oncology (2013)

    Fulltext@MSK | Save
  • A phase II study of 18f-FDG PET guided optimization of neoadjuvant chemotherapy for resectable non-small cell lung cancer
    Meeting Abstract

    Chaft, J. E.; Hellmann, M. D.; Dunphy, M.; Jappe, W.; Sima, C. S.; Downey, R. J.; Travis, W. D.; Azzoli, C. G.; Kris, M. G.
    Journal of Thoracic Oncology (2013)

    Fulltext@MSK | Save
  • Phase 2 study of the GI-4000 KRAS vaccine following curative therapy in patients with stage I-III lung adenocarcinoma harboring a KRAS G12C, G12D, G12V or G12R mutation
    Meeting Abstract

    Chaft, J. E.; Arcila, M.; Patel, P.; Apelian, D. M.; Mattson, A.; Coeshott, C.; Kris, M. G.; Azzoli, C. G.
    Journal of Thoracic Oncology (2013)

    Fulltext@MSK | Save
  • Structural, biochemical, and clinical characterization of epidermal growth factor receptor (EGFR) exon 20 insertion mutations in lung cancer
    Journal Article

    Yasuda, H.; Park, E.; Yun, C. H.; Sng, N. J.; Lucena-Araujo, A. R.; Yeo, W. L.; Huberman, M. S.; Cohen, D. W.; Nakayama, S.; Ishioka, K.; more...
    Science Translational Medicine (2013)

    Fulltext@MSK | Save
  • Prognostic factors for postresection recurrent NSCLC treated with definitive radiation therapy
    Meeting Abstract

    Garay, E.; Rimner, A.; Foster, A.; Hsu, M.; Zhang, Z.; Huang, J.; Chaft, J. E.; Rosenzweig, K. E.; Wu, A. J.
    International Journal of Radiation Oncology, Biology, Physics (2013)

    Fulltext@MSK | Save
  • Phase II study of docetaxel and vinorelbine as adjuvant chemotherapy for resected non-small cell lung cancers
    Journal Article

    Chaft, J. E.; Rekhtman, N.; Sima, C. S.; Rusch, V.; Kris, M. G.; Zakowski, M.; Azzoli, C. G.
    Cancer Chemotherapy and Pharmacology (2013)

    Fulltext@MSK | Save
  • Risk of hemoptysis in patients with resected squamous cell and other high-risk lung cancers treated with adjuvant bevacizumab
    Journal Article

    Hellmann, M. D.; Chaft, J. E.; Rusch, V.; Ginsberg, M. S.; Finley, D. J.; Kris, M. G.; Price, K. A. R.; Azzoli, C. G.; Fury, M. G.; Riely, G. J.; more...
    Cancer Chemotherapy and Pharmacology (2013)

    Fulltext@MSK | Save